Early Diagnosis Improvement of Chlamydia Infections
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: Thursday 26th, September 2024
External Deadline: Monday 7th, October 2024
Description
Pfizer Global Medical Grants & Partnerships (GMGP) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMGP competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.
Date RFP Issued: August 13, 2024
Geographic Scope: Global, prioritizing cross-regional and international reach
Clinical Area: Chlamydia-Anti infectives
Link to full RFP: Early Diagnosis Improvement of Chlamydia Infections
Application Due Date: October 7, 2024
Specific Area of Interest: Potential applicants are encouraged to develop educational programs to identify and address the educational needs, barriers, and gaps for early diagnosis of chlamydia.
Under this RFP, grants will be offered to support evidence-based programs, with a high reach potential, aiming to improve routine screening practices, appropriate diagnostic methods for chlamydia, use of latest guidelines, and best practices for early diagnosis of chlamydia infections. Educational programs with a focus on addressing specific challenges faced by marginalized populations are also within scope.
Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Talita Honorato-Rzeszewicz (Talita.Honorato-Rzeszewicz@pfizer.com).